You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Setting the Stage for Lowering IOP in Glaucoma: Solving the Mystery of Meds, MIGS, or Combination Treatment

  • Authors: Jonathan S. Meyers, MD
  • CME Released: 11/15/2019
  • Valid for credit through: 11/15/2020, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for glaucoma specialists, comprehensive ophthalmologists, and other healthcare providers interested in glaucoma management.

The goal of this activity is to enhance physicians' knowledge of pharmaceutical and surgical approaches to glaucoma treatment, as well as selecting and tailoring individualized glaucoma treatment based on patient characteristics.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Safety and efficacy of pharmaceutical and surgical (minimally invasive glaucoma surgery [MIGS], lasers, etc) approaches to glaucoma treatment
    • Similarities and differences in mechanisms of surgical and nonsurgical approaches to glaucoma treatment
  • Have greater competence related to
    • Selecting first-line treatment strategies for patients with glaucoma 
    • Selecting an intraocular pressure (IOP)-lowering strategy for patients who have not adequately responded to initial treatment
  • Demonstrate greater confidence in their ability to
    • Tailor glaucoma treatment based on individual patient characteristics


As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


  • Jonathan S. Myers, MD

    Chief, Glaucoma Service
    Wills Eye Hospital
    Associate Professor
    Sidney Kimmel Medical College at Thomas Jefferson University
    Philadelphia, Pennsylvania


    Disclosure: Jonathan S. Myers, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Aerie; Allergan, Inc.; Glaukos; MicroOptx
    Served as a speaker or a member of a speakers bureau for: Aerie; Allergan, Inc.
    Received grants for clinical research from: Aerie; Allergan, Inc.; Bausch & Lomb Inc.; Diopsys; Glaukos; Heidelberg; Novartis Pharmaceuticals Corporation; SightSciences; Zeiss


  • Pakinam Aboulsaoud, Pharm D

    Medical Education Director, Medscape, LLC


    Disclosure: Pakinam Aboulsaoud, PharmD, has disclosed no relevant financial relationships.

  • Carol Smyth, MB

    Director of Content Development, Medscape, LLC

    Disclosure: Carol Smyth, MB, has disclosed no relevant financial relationships.

Content Reviewers

  • Esther Nyarko, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

    For Physicians

  • The Wills Eye Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  The Wills Eye Hospital designates the enduring portion of this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    [email protected]

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Setting the Stage for Lowering IOP in Glaucoma: Solving the Mystery of Meds, MIGS, or Combination Treatment

Authors: Jonathan S. Meyers, MDFaculty and Disclosures

CME Released: 11/15/2019

Valid for credit through: 11/15/2020, 11:59 PM EST




  • Print